VITAS® Healthcare Honored With Inaugural Founders Spirit Award by the National Black Nurses Association, Inc.
August 14, 2024 10:26 ET
|
VITAS Healthcare
VITAS Healthcare, the nation's leading end-of-life care provider, receives the inaugural Founders Spirit Award from the National Black Nurses Association.
BlueSphere Bio Accepted as Member of Johnson & Johnson Innovation-JLABS
August 14, 2024 10:15 ET
|
BlueSphere Bio
PITTSBURGH, Aug. 14, 2024 (GLOBE NEWSWIRE) -- BlueSphere Bio, a drug development company focused on the discovery of novel T-cell receptor (TCR) based therapies, announced it has been accepted as a...
At 5.9% CAGR, Medical Flexible Packaging Market Share to Reach USD 33.70 Billion by 2034: Prophecy Market Insights
August 14, 2024 10:03 ET
|
PMI
Covina, Aug. 14, 2024 (GLOBE NEWSWIRE) -- According to Prophecy Market Insights, the global medical flexible packaging market size and share is projected to grow from USD 19.99 Billion in 2024 and...
37 New Dental Graduates Join Benevis Practices Nationwide to Support Underserved Families’ Oral Health
August 14, 2024 10:00 ET
|
Benevis
Atlanta, GA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Benevis, a leading dental healthcare and orthodontics delivery organization committed to providing quality care to underserved communities, is proud to...
Healthcare Business Intelligence Market Size to Reach USD 27.63 Billion By 2032, With a Growing CAGR of 14% | Research by SNS Insider
August 14, 2024 08:54 ET
|
SNS Insider pvt ltd
Pune, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Healthcare Business Intelligence Market Size & Share: “According to SNS Insider Research, The Healthcare Business Intelligence (BI) Market Size was...
Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s Disease and Plans to Pursue a Development Partnership
August 14, 2024 08:30 ET
|
Vaccinex, Inc.
Company reviews goals and significance of the clinical trial and outlines development and partnering strategy
Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range
August 14, 2024 08:30 ET
|
Oragenics
• ONP-002 stability eliminates need for cumbersome cold storage• No FDA-approved pharmaceutical treatment available for concussion SARASOTA, Fla., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Oragenics,...
RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
August 14, 2024 08:30 ET
|
RenovoRx, Inc.
Phase III clinical trial is evaluating RenovoGem™ for the treatment of Locally Advanced Pancreatic Cancer UNMC opened enrollment of TIGeR-PaC in June 2024 and joins esteemed clinical sites throughout...
AI in Drug Discovery Market: $0.9B to $4.9B Growth Forecast (2023-2028) | MarketsandMarkets™
August 14, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Aug. 14, 2024 (GLOBE NEWSWIRE) -- The "AI in Drug Discovery Market Size, Share & Trends by Offering, Process (Target selection, Validation, Lead generation, optimization), Drug Design...
Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr
August 14, 2024 08:00 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients,...